SK Life Science will also host the "Prioritizing Seizure Treatments Through Real-World Patient Case Studies Symposium," an expert led panel to advance the discussion regarding the unmet need for ...
"Road to Reduction" Begins Airing Today Raising Awareness of XCOPRI® (cenobamate tablets) CV and the Journey to Seizure Management for People Living with Epilepsy PARAMUS, N.J., May 19, 2025 ...
It’s boots on the ground, or rather in the office, for SK Life Science’s latest sales push aimed at getting its target, i.e., neurologists, to pay attention. The unconventional approach of “The Shoe ...
PARAMUS, N.J., April 4, 2025 /PRNewswire/ -- SK Life Science, Inc., a global leader in developing treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., ...
SK Innovation E&S, the energy unit of South Korea's SK Group, said Tuesday it has begun production at an offshore gas field ...
KING OF PRUSSIA, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs (formerly Proteovant Therapeutics) a subsidiary of SK Biopharmaceuticals, Co., Ltd., showcased its cutting-edge targeted ...
SK hynix’s plan to set up an artificial intelligence (AI) solutions firm in the United States is raising questions about how ...
KING OF PRUSSIA, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, Co., Ltd., a global biotech focused on the research, development, and ...
SK Bioscience CEO Ahn Jae-yong, left, and Sanofi's Jean-Francois Toussant, global head of vaccine research and development, pose for the photo after a signing ceremony. [SK BIOSCIENCE] SK bioscience ...
SK bioscience said on the 9th that it introduced the quadrivalent meningococcal conjugate vaccine "MenQuadfi" in Korea in cooperation with Sanofi Korea. The vaccine can be given from 6 weeks of age ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...